Benjamin Jackson

Stock Analyst at Jefferies

(0.27)

# 4,408

Out of 5,163 analysts

2

Total ratings

n/a

Success rate

-9.42%

Average return

Main Sectors:

Top Industries:

Biotechnology Drug Manufacturers - Specialty & Generic

Stocks Rated by Benjamin Jackson

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	GMAB Genmab	Reinstates: Buy	$42	$26.14	+58.76%	1	Feb 17, 2026
	EVO Evotec SE	Downgrades: Hold	$8.7 → $3.8	$2.31	+64.50%	1	Oct 7, 2024

Genmab

Feb 17, 2026

Reinstates: Buy

Price Target: $42

Current: $26.14

Upside: +58.76%

Evotec SE

Oct 7, 2024

Downgrades: Hold

Price Target: $8.7 → $3.8

Current: $2.31

Upside: +64.50%